Research Study

A Long Term Follow-up Registry Study of Subjects Who Did Not Achieve Sustained Virologic Response in Gilead-Sponsored Trials in Subjects With Chronic Hepatitis C Infection
Principal Investigator 
Eric M. Yoshida

Overview

Body Locations and Systems 
Hepatitis C
Health Conditions 
Hepatitis C Chronic
ClinicalTrials.gov# 
NCT01457768
Status 
Closed to Recruitment
Study Start/End 
Nov 20, 2012 to Nov 20, 2017
Locations 
Diamond Health Care Centre, Vancouver General Hospital
Name/Title 
Kirby Lau, Study Coordinator
Phone 
604-875-5223
Email Address 
kirby.lau@vch.ca
Purpose of Study 

This Registry is designed to obtain long term data on participants who have failed to achieve sustained virologic response (SVR) while receiving at least one Gilead oral antiviral agent (OAV) in a previous Gilead-sponsored hepatitis C virus (HCV) study.

Eligibility 

Visit ClinicalTrials.gov for more information. 

Disclaimer 

Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific clinical research trials only. If you have specific questions which require clinical expertise, please call your primary care physician.